Total Payments
$580.93
2024 Payments
$72.82
Companies
18
Transactions
36
Medicare Patients
3,495
Medicare Billing
$556,050
Payment Breakdown by Category
Food & Beverage$568.77 (97.9%)
Education$12.16 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $568.77 | 35 | 97.9% |
| Education | $12.16 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $120.71 | 9 | $0 (2021) |
| Horizon Therapeutics plc | $72.08 | 5 | $0 (2022) |
| Boston Scientific Corporation | $50.69 | 1 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $39.46 | 3 | $0 (2020) |
| Stimwave Technologies Incorporated | $31.96 | 2 | $0 (2019) |
| ABBVIE INC. | $31.87 | 2 | $0 (2022) |
| ARBOR PHARMACEUTICALS, INC. | $30.89 | 2 | $0 (2018) |
| TerSera Therapeutics LLC | $28.61 | 2 | $0 (2019) |
| Bioventus LLC | $23.02 | 1 | $0 (2021) |
| Flexion Therapeutics, Inc. | $22.13 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.82 | 2 | Boston Scientific Corporation ($50.69) |
| 2022 | $102.51 | 7 | ABBVIE INC. ($31.87) |
| 2021 | $110.76 | 6 | Horizon Therapeutics plc ($46.68) |
| 2020 | $54.53 | 4 | Nevro Corp. ($17.22) |
| 2019 | $187.56 | 13 | Allergan Inc. ($88.99) |
| 2018 | $52.75 | 4 | ARBOR PHARMACEUTICALS, INC. ($30.89) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $50.69 | General |
| Category: General - Pain Management_NMD | ||||||
| 07/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: NEUROLOGY | ||||||
| 11/10/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Education | In-kind items and services | $12.16 | General |
| Category: Migraine | ||||||
| 09/09/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/26/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: PENNSAID | ||||||
| 07/14/2022 | BAUDAX BIO INC. | ANJESO (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Pain Management | ||||||
| 07/12/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/18/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: PENNSAID | ||||||
| 04/09/2022 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Pain Management | ||||||
| 12/07/2021 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: PENNSAID | ||||||
| 10/13/2021 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Analgesic | ||||||
| 08/23/2021 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: PENNSAID | ||||||
| 07/20/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/25/2021 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: PENNSAID | ||||||
| 05/18/2021 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 02/06/2020 | KCI USA, Inc. | — | Food and Beverage | In-kind items and services | $11.66 | General |
| 02/03/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.13 | General |
| Category: Opioid Analgesic | ||||||
| 01/21/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/07/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/18/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/11/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.71 | General |
| Category: Opioid Analgesic | ||||||
| 09/18/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/22/2019 | TerSera Therapeutics LLC | PRIALT (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: PAIN | ||||||
| 08/19/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 06/24/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 848 | 1,261 | $650,444 | $126,298 |
| 2022 | 15 | 905 | 1,905 | $801,209 | $161,011 |
| 2021 | 19 | 843 | 1,605 | $915,252 | $149,686 |
| 2020 | 18 | 899 | 1,420 | $855,623 | $119,055 |
Total Patients
3,495
Total Services
6,191
Medicare Billing
$556,050
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 170 | 259 | $192,696 | $50,114 | 26.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 216 | 368 | $64,400 | $22,370 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 282 | $117,876 | $21,571 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $34,140 | $6,264 | 18.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 23 | 28 | $39,445 | $5,712 | 14.5% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 32 | 37 | $21,386 | $5,678 | 26.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 30 | 57 | $62,604 | $5,276 | 8.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 29 | 55 | $31,536 | $3,065 | 9.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 23 | 28 | $44,050 | $1,802 | 4.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 14 | 24 | $20,112 | $1,644 | 8.2% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 12 | 13 | $5,213 | $1,458 | 28.0% |
| 64451 | Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | Facility | 2023 | 11 | 18 | $12,636 | $1,005 | 8.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 25 | 29 | $4,350 | $338.85 | 7.8% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 183 | 293 | $217,992 | $57,299 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 516 | $215,688 | $40,385 | 18.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 230 | 536 | $93,800 | $32,725 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $35,230 | $7,102 | 20.2% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 21 | 27 | $15,606 | $4,167 | 26.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 19 | 20 | $26,780 | $4,149 | 15.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 17 | 31 | $34,968 | $3,061 | 8.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 26 | 38 | $31,844 | $2,732 | 8.6% |
| 64451 | Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | Facility | 2022 | 20 | 31 | $21,762 | $2,190 | 10.1% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Facility | 2022 | 11 | 11 | $17,402 | $1,792 | 10.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 17 | 31 | $16,352 | $1,762 | 10.8% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 11 | 15 | $6,015 | $1,691 | 28.1% |
About Dr. James Hunt, MD
Dr. James Hunt, MD is a Anesthesiology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013136340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Hunt, MD has received a total of $580.93 in payments from pharmaceutical and medical device companies, with $72.82 received in 2024. These payments were reported across 36 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($568.77).
As a Medicare-enrolled provider, Hunt has provided services to 3,495 Medicare beneficiaries, totaling 6,191 services with total Medicare billing of $556,050. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Location Little Rock, AR
- Active Since 04/25/2007
- Last Updated 01/14/2026
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1013136340
Products in Payments
- BOTOX (Biological) $152.58
- PENNSAID (Drug) $72.08
- XTAMPZA (Drug) $39.46
- Horizant (Drug) $30.89
- PRIALT (Drug) $28.61
- Durolane (Device) $23.02
- VYEPTI (Biological) $22.13
- Zilretta (Drug) $22.13
- ZTLido (Drug) $20.86
- Nalu Neurostimulation System (Device) $17.33
- Senza Spinal Cord Stimulation System (Device) $17.22
- ANJESO (Drug) $15.75
- LYRICA (Drug) $12.40
- Trudhesa (Drug) $12.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Little Rock
Julio Olaya, M.d, M.D
Anesthesiology — Payments: $22,896
Anesthesiology $22,896
Gregory Smith, M.d, M.D
Anesthesiology — Payments: $15,070
Anesthesiology $15,070
Majid Saleem, Md, MD
Anesthesiology — Payments: $10,579
Anesthesiology $10,579
Dr. Aparna Jindal, Md, MD
Anesthesiology — Payments: $6,860
Anesthesiology $6,860
Ahmed Ghaleb, Md, MD
Anesthesiology — Payments: $6,435
Anesthesiology $6,435
Mr. Mikhail Ivanovsky, Md, MD
Anesthesiology — Payments: $4,564
Anesthesiology $4,564